Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00508547 · ClinicalTrials.gov registry record

Psoriasis Longitudinal Assessment and Registry

A clinical trial of Psoriasis, sponsored by Janssen Scientific Affairs.

Active
Registry status
15,842
Enrollment target
20
Study locations

NCT00508547 is a study of Psoriasis that is active but no longer recruiting, run by Janssen Scientific Affairs. The registered enrollment target is 15,842 participants, above the 362-participant average among 125 other Psoriasis trials with a reported enrollment target (4276% higher). The trial reports 20 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00508547, a study of Psoriasis, is active but no longer recruiting, sponsored by Janssen Scientific Affairs.

ACTIVE NOT RECRUITING
Registry status
15,842 participants
Enrollment target
20
Study locations

Study Summary

The purpose of this study is to further evaluate the safety of infliximab, ustekinumab, and guselkumab in patients with plaque and other forms of psoriasis. The study also includes patients receiving other therapies, such as non-biologic and other biologic agents. The registry also evaluates patient and disease characteristics, including patient-reported assessment of psoriatic arthritis (PsA); and clinical and quality of life outcomes.

Conditions Studied

Psoriasis

Study Locations (20)

California

  • - Bakersfield
  • - Clovis
  • - Fountain Valley
  • - Fresno
  • - Loma Linda
  • - Los Angeles
  • - Mountain View
  • - Oxnard
  • - Redding
  • - Rolling Hills Estates
  • - San Diego
  • - San Ramon
  • - Santa Monica

Alabama

  • - Birmingham
  • - Florence
  • - Huntsville

Arizona

  • - Phoenix
  • - Scottsdale
  • - Tucson

Arkansas

  • - Rogers

Trial Details

FieldValue
Enrollment Target 15,842 participants
Start Date 2007-06-21
Est. Completion 2030-12-31

Sponsor

Janssen Scientific Affairs

37 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00508547

The ClinicalTrials.gov registry entry for NCT00508547 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 15,842 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 362-participant average among 125 other Psoriasis trials with a reported enrollment target (4276% higher). The listed sponsor is Janssen Scientific Affairs, which has 37 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Psoriasis appearing as the primary indexed condition, and to 0 interventions.

NCT00508547 reports 20 study locations spanning 4 distinct geographic areas - top geographies include California, Alabama, Arizona.

Frequently Asked Questions

What is clinical trial NCT00508547 about?

NCT00508547 is a clinical study titled "Psoriasis Longitudinal Assessment and Registry". The purpose of this study is to further evaluate the safety of infliximab, ustekinumab, and guselkumab in patients with plaque and other forms of psoriasis. The study also includes patients receiving other therapies, such as non-biologic and other biologic agents. The registry also evaluates patient...

What is the current status of trial NCT00508547?

This trial is currently active not recruiting. The enrollment target is 15,842 participants. The study started on 2007-06-21. Estimated completion is 2030-12-31.

What conditions does trial NCT00508547 study?

This clinical trial studies the following conditions: Psoriasis.

Who is sponsoring clinical trial NCT00508547?

This trial is sponsored by Janssen Scientific Affairs, which has 37 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00508547 being conducted?

This trial has 20 study locations across Alabama, Arizona, Arkansas, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Psoriasis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Psoriasis

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.